0001683168-19-001919.txt : 20190617
0001683168-19-001919.hdr.sgml : 20190617
20190617162012
ACCESSION NUMBER: 0001683168-19-001919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190605
FILED AS OF DATE: 20190617
DATE AS OF CHANGE: 20190617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dye Justin
CENTRAL INDEX KEY: 0001654539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55450
FILM NUMBER: 19901619
MAIL ADDRESS:
STREET 1: C/O MEDICINE MAN TECHNOLOGIES, INC.
STREET 2: 4880 HAVANA STREET, SUITE 201
CITY: DENVER
STATE: CO
ZIP: 80239
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medicine Man Technologies, Inc.
CENTRAL INDEX KEY: 0001622879
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 465289499
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4880 HAVANA STREET
STREET 2: SUITE 102 SOUTH
CITY: DENVER
STATE: CO
ZIP: 80239
BUSINESS PHONE: 303-371-0387
MAIL ADDRESS:
STREET 1: 4880 HAVANA STREET
STREET 2: SUITE 102 SOUTH
CITY: DENVER
STATE: CO
ZIP: 80239
4
1
ownership.xml
X0306
4
2019-06-05
0
0001622879
Medicine Man Technologies, Inc.
MDCL
0001654539
Dye Justin
C/O MEDICINE MAN TECHNOLOGIES, INC.
4880 HAVANA STREET, SUITE 201
DENVER
CO
90239
1
0
0
0
Common Stock
2019-06-05
4
P
0
1500000
2.00
A
1500000
I
See footnote 1
Option to purchase common stock
3.72
2019-06-05
4
A
0
300000
0
A
2019-06-05
2022-06-05
Common Stock
300000
300000
D
Warrant to purchase common stock
3.50
2019-06-05
4
P
0
1500000
A
2019-06-05
2022-06-05
Common Stock
1500000
1500000
I
See footnote 1
On June 5, 2019, Medicine Man Technologies, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with Dye Capital Cann Holdings, LLC (the "Investor"). The Reporting Person has voting and investment control of the securities owned by the Investor and disclaims beneficial ownership of the securities for purposes of Section 16 except to the extent of the Reporting Person's pecuniary interest therein. Pursuant to the Purchase Agreement, the Investor purchased, in a private placement 1,500,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at a price of $2.00 per share and warrants (the "Warrants") to purchase 1,500,000 shares of Common Stock. The Warrants are for a term of three years and are exercisable at a price of $3.50.
The Option vests in 1/2 increments on the one (1) and two (2) year anniversaries of the date of grant.
/s/ Justin Dye
2019-06-14